The physical repair and restoration of a completely damaged pathway in the brain has not been achieved previously. In a previous study, using excitatory amino acid bridging and fetal neural transplantation, we demonstrated that a bridged mesencephalic transplant in the substantia nigra generated an artificial nerve pathway that reinnervated the striatum of 6-hydroxydopamine (6-OHDA)-lesioned rats. In the current study, we report that a bridged mesencephalic transplant can anatomically, neurochemically, and functionally reinstate the 6-OHDA-eradicated nigro-striatal pathway. An excitatory amino acid, kainic acid, laid down in a track during the transplant generated a trophic environment that effectively guided the robust growth of transplant...
Poor cell survival and striatal reinnervation are two of the postulated limiting factors of fetal ve...
In spite of partial success in treating Parkinson's disease using ectopically placed grafts of dopam...
Abstract-Parkinson's disease is caused by degeneration of dopaminergic neurons in the ventral mesenc...
Parkinson\u27s disease is characterized by progressive degeneration of substantia nigra (SN) and sub...
Previous studies have shown that the functional efficacy of intrastriatal transplants of fetal dopam...
C1 - Journal Articles RefereedCell replacement therapy for Parkinson's disease has predominantly foc...
The derivation of dopamine neurons from human embryonic stem cells (hESCs) now offers a promising al...
Parkinson’s disease is a progressive neurodegenerative disease that affects 1-2% of people over 65, ...
Transplants of fetal dopamine neurons can be used to restore dopamine neurotransmission in animal mo...
Intrastriatal transplantation of dopaminergic neurons can restore striatal dopamine levels and impro...
The motor symptoms of Parkinson’s disease (PD) are caused by the loss of dopamine in the striatum th...
Although neurotransplantation of primary fetal cells into the striatum of patients with Parkinson’s ...
Under appropriate conditions, neural tissues transplanted into the adult mammalian brain can survive...
Damage to the adult mammalian central nervous system (CNS), either by traumatic injury or disease, u...
Stem cells have been increasingly recognized as a potential tool to replace or support cells damaged...
Poor cell survival and striatal reinnervation are two of the postulated limiting factors of fetal ve...
In spite of partial success in treating Parkinson's disease using ectopically placed grafts of dopam...
Abstract-Parkinson's disease is caused by degeneration of dopaminergic neurons in the ventral mesenc...
Parkinson\u27s disease is characterized by progressive degeneration of substantia nigra (SN) and sub...
Previous studies have shown that the functional efficacy of intrastriatal transplants of fetal dopam...
C1 - Journal Articles RefereedCell replacement therapy for Parkinson's disease has predominantly foc...
The derivation of dopamine neurons from human embryonic stem cells (hESCs) now offers a promising al...
Parkinson’s disease is a progressive neurodegenerative disease that affects 1-2% of people over 65, ...
Transplants of fetal dopamine neurons can be used to restore dopamine neurotransmission in animal mo...
Intrastriatal transplantation of dopaminergic neurons can restore striatal dopamine levels and impro...
The motor symptoms of Parkinson’s disease (PD) are caused by the loss of dopamine in the striatum th...
Although neurotransplantation of primary fetal cells into the striatum of patients with Parkinson’s ...
Under appropriate conditions, neural tissues transplanted into the adult mammalian brain can survive...
Damage to the adult mammalian central nervous system (CNS), either by traumatic injury or disease, u...
Stem cells have been increasingly recognized as a potential tool to replace or support cells damaged...
Poor cell survival and striatal reinnervation are two of the postulated limiting factors of fetal ve...
In spite of partial success in treating Parkinson's disease using ectopically placed grafts of dopam...
Abstract-Parkinson's disease is caused by degeneration of dopaminergic neurons in the ventral mesenc...